Several studies have demonstrated that DARPP-32 and t-DARPP protect cancer cells from drug-induced apoptosis, which is dependent upon their T75 phosphorylation residue9,10 and involves upregulation of Akt and Bcl2 proteins16,18,19. Here, BCL2 is linked to cancer.